kkumar

kkumar

157 Hits kkumar Nov 16, 2025, 5:40 PM
At the center of this market sits JAKAFI (ruxolitinib), the JAK1/2 inhibitor that revolutionized the treatment of PV, particularly for patients intolerant of or resistant to hydroxyurea
Read More
73 Hits kkumar Nov 13, 2025, 2:10 PM
Ongoing evaluation of clinical progress and scientific developments will remain vital for healthcare decision-makers and industry stakeholders monitoring this evolving...
Read More
59 Hits kkumar Nov 13, 2025, 10:55 AM
These drones incorporate advanced navigation mechanisms, live tracking features, and cargo management systems, enabling them to reach isolated or densely...
Read More
122 Hits kkumar Nov 11, 2025, 4:50 PM
These advances are expected to enhance personalized care delivery dramatically and provide patients worldwide with smarter, more predictive health tools
Read More
166 Hits kkumar Nov 10, 2025, 4:34 PM
Jordan has created a substantial regulatory structure for biosimilars, implementing directives that reference EMA benchmarks since 2015
Read More
135 Hits kkumar Nov 9, 2025, 5:20 PM
Unlike existing GLP-1 agents, this molecule utilizes a fully biased approach to maximize desired metabolic outcomes and minimize untoward effects
Read More
162 Hits kkumar Nov 9, 2025, 3:52 PM
Advances in drug development are offering new hope for better long-term management, but the lack of generic competition means that...
Read More
172 Hits kkumar Nov 8, 2025, 8:02 PM
The therapeutic approach to depression is experiencing a remarkable evolution as pharmaceutical and biotechnology companies focus on developing faster-acting, safer,...
Read More
96 Hits kkumar Nov 3, 2025, 6:06 PM
With pharma tariffs on the rise, industry attention centers on enhanced efficiency, domestic production expansion, and alternative supply sources
Read More
113 Hits kkumar Oct 16, 2025, 11:04 AM
While challenges exist, the continued development of medical robots and AI-powered automation will play a central role in shaping the...
Read More